The Report
Verified funding, headquarters, and leadership news from the world's most innovative businesses
196 reports and counting
Eikon Therapeutics raises $106M Series C at $1B valuation
Eikon Therapeutics raises $106M in Series C at $1B valuation. Biotech startup developing cancer-fighting therapeutic assets...
Eikon Therapeutics Raises $350.7M in Series D
Eikon Therapeutics, a HealthTech company based in Hayward, CA, has raised $350.7M in Series D at a $3B valuation led by Andreessen Horowitz Bio, ARCH Venture Partners.
Eikon Therapeutics raises $350.7M Series D at $3B valuation
Eikon Therapeutics raises $350.7M in Series D at $3B valuation. Drug discovery using advanced microscopy...
Eikon Therapeutics Raises $350.7M Series D to Transform Biotech
Eikon Therapeutics has secured $350.7M Series D in funding to accelerate growth and innovation in the biotech sector. Drug discovery company using advanced microscopy and computation to observe protein dynamics in living cells...
Arnatar Therapeutics raises $52M Series A
Arnatar Therapeutics raises $52M in Series A. Developing therapeutics for autoimmune and inflammatory diseases...
Denali Therapeutics raises $217M Series C at $5B valuation
Denali Therapeutics raises $217M in Series C at $5B valuation. Neurodegeneration therapeutics...
Strand Therapeutics raises $153M Series B
Strand Therapeutics raises $153M in Series B. mRNA-based therapeutics developer with novel cancer treatment platform...
Seres Therapeutics raises $113M Series E at $450M valuation
Seres Therapeutics raises $113M in Series E at $450M valuation. Microbiome therapeutic platform...
Crystalys Therapeutics raises $205M Series B at $900M valuation
Crystalys Therapeutics raises $205M in Series B at $900M valuation. Developing novel therapeutics for neurodegenerative diseases...
Showing 9 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.